Global Pruritus Therapeutics Market Projected To Reach USD 16.37 Billion By 2028.


rahul wagh

5 months ago | 3 min read

The global Pruritus Therapeutics Market was estimated at USD 12.11 billion in 2021 and is projected to reach USD 16.37 billion by 2028, growing at a CAGR of 4.4% over the analysis period.

Pruritus skin is an uncomfortable and embarrassing feeling that makes people scratch. Dry skin is a common cause of itching, also known as itching. It is more common in the elderly because the skin dries out with age. The skin may look normal, red, rough or bumpy, depending on the cause of the itching. Repeated scratching can cause raised, thickened skin that can bleed or become infected. Many people find relief through self-care methods, such as frequent moisturizing creams, gentle cleansers, and warm baths. For long-lasting relief, it is necessary to identify and treat the cause of the itchy skin. Itching can also be caused by medical conditions such as kidney failure, liver disease, thyroid disease, cancer and diabetes.

Antibiotics, antifungals, anticonvulsants and some natural remedies such as topical applications of coconut oil, vitamin E and honey are used to treat itching. The increase in the number of people with chronic diseases and the growth of the geriatric population are the two main factors that should drive the development of the itch treatment market during the forecast period.

Download a Free Sample Copy of the Market Report: -

The Major Players in The Global Pruritus Therapeutics Market:

  • AbbVie Inc.
  • Sanofi SA
  • Galderma Laboratories LP
  • EPI Health LLC
  • Cara Therapeutics
  • Actavis
  • Trevi Therapeutics
  • Novartis AG
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Sun Pharmaceuticalc
  • GlaxoSmithKlinePLC
  • Glenmark Pharmaceuticals Ltd.
  • Abbott Laboratories, and Other Major Players.

Market has segmented the Global Pruritus Therapeutics Market on the basis of type, application, and region:

By Disease Type :

  • Allergic Contact Dermatitis
  • Atopic Dermatitis
  • Psoriasis
  • Urticaria
  • Others

By Drug Class:

  • Calcineurin Inhibitors
  • Corticosteroids
  • Counterirritants
  • Immunosuppressant
  • Antihistamines
  • Others

By Regional Outlook (Revenue, USD Billion, 2022 – 2028)

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)

If You Have Any Query of Global Pruritus Therapeutics Market, Visit.@

Covid-19 Impact and Recovery Analysis on Industry:

The extreme and constant stress associated with caring for a chronic skin condition, as well as the risk of contracting COVID-19, add to the patient's worries. Although SARS-CoV-2 is mainly responsible for respiratory problems and not skin diseases, it has a significant impact on dermatological and dermatological patients. The stress, harmful substances and allergens contained in disinfectants and cleansers can aggravate many chronic skin diseases. During this extraordinary time, the dermatology community has faced unprecedented challenges in improving the mental health and quality of life of people living with a chronic disease such as AD. During the COVID-19 pandemic, atopic dermatitis was associated with lower overall health ratings, lower life satisfaction, and lower mental health-related quality of life. As vaccination coverage increases and cases of infection decrease, the demand for itch medications is expected to increase during the forecast period.

Reasons to purchase the report:

  • Visualize the composition of the Global Pruritus Therapeutics Market products in terms of Product and application highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the Global Pruritus Therapeutics Market by analyzing trends and co-development deals.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Table of Content:

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Drug Class
 3.2 By Disease Type
 3.3 By Route Of Administration

To be continued…….

Purchase This Report:-   

Related Reports:

About us:

Introspective Market Research ( is a visionary research consulting firm dedicated to assisting our clients to grow and have a successful impact on the market. Our team at IMR is ready to assist our clients to flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, that specializes in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1-773-382-1047

LinkedinTwitter |Facebook

Email :




Created by

rahul wagh







Related Articles